DeacetylcinobufaginCAS# 4026-95-3 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
| Cas No. | 4026-95-3 | SDF | Download SDF |
| PubChem ID | 314718 | Appearance | Powder |
| Formula | C24H32O5 | M.Wt | 400.52 |
| Type of Compound | Steroids | Storage | Desiccate at -20°C |
| Synonyms | Deacetylcinobufagin | ||
| Solubility | DMSO : ≥ 26 mg/mL (64.92 mM) *"≥" means soluble, but saturation unknown. | ||
| SMILES | CC12CCC(CC1CCC3C2CCC4(C35C(O5)C(C4C6=COC(=O)C=C6)O)C)O | ||
| Standard InChIKey | IXZHDDUFQVXHIL-UHFFFAOYSA-N | ||
| Standard InChI | InChI=1S/C24H32O5/c1-22-9-7-15(25)11-14(22)4-5-17-16(22)8-10-23(2)19(13-3-6-18(26)28-12-13)20(27)21-24(17,23)29-21/h3,6,12,14-17,19-21,25,27H,4-5,7-11H2,1-2H3 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | Deacetylcinobufagin shows the potent activities against human carcinoma cervicis (Hela) and malignant melanoma (A375) cells in vitro. |
| In vitro | Efficient isolation and purification of five products from microbial biotransformation of cinobufagin by high-speed counter-current chromatography.[Pubmed: 20574960]J Sep Sci. 2010 Aug;33(15):2272-7.
|
Deacetylcinobufagin Dilution Calculator
Deacetylcinobufagin Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 2.4968 mL | 12.4838 mL | 24.9675 mL | 49.9351 mL | 62.4189 mL |
| 5 mM | 0.4994 mL | 2.4968 mL | 4.9935 mL | 9.987 mL | 12.4838 mL |
| 10 mM | 0.2497 mL | 1.2484 mL | 2.4968 mL | 4.9935 mL | 6.2419 mL |
| 50 mM | 0.0499 mL | 0.2497 mL | 0.4994 mL | 0.9987 mL | 1.2484 mL |
| 100 mM | 0.025 mL | 0.1248 mL | 0.2497 mL | 0.4994 mL | 0.6242 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
Desacetylcinobufagin is a natural compound used for microbial transformation.
References:
[1]. Zhu ZT, et al. Novel microbial transformation of desacetylcinobufagin by Fusarium avenaceum AS 3.4594. J Asian Nat Prod Res. 2013;15(3):294-9.
- Firategrast
Catalog No.:BCC1575
CAS No.:402567-16-2
- NSC 693868
Catalog No.:BCC7208
CAS No.:40254-90-8
- DMeOB
Catalog No.:BCC7213
CAS No.:40252-74-2
- Acetylcimigenol 3-O-alpha-L-arabinopyranside
Catalog No.:BCN1447
CAS No.:402513-88-6
- ONO-AE3-208
Catalog No.:BCC1822
CAS No.:402473-54-5
- Glycitin
Catalog No.:BCN5895
CAS No.:40246-10-4
- 5-O-Feruloylquinic acid
Catalog No.:BCN3788
CAS No.:40242-06-6
- H-Hyp-OMe.HCl
Catalog No.:BCC3248
CAS No.:40216-83-9
- H-Orn-OMe.2HCl
Catalog No.:BCC3001
CAS No.:40216-82-8
- Fmoc-β-Homo-Gln(Trt)-OH
Catalog No.:BCC2647
CAS No.:401915-55-7
- Fmoc-β-homo-Arg(Pbf)-OH
Catalog No.:BCC2649
CAS No.:401915-53-5
- Andarine
Catalog No.:BCC1168
CAS No.:401900-40-1
- SB 399885 hydrochloride
Catalog No.:BCC7595
CAS No.:402713-81-9
- 7-Methoxyneochamaejasmine A
Catalog No.:BCN3134
CAS No.:402828-38-0
- DR 4485 hydrochloride
Catalog No.:BCC7990
CAS No.:402942-53-4
- Telaprevir (VX-950)
Catalog No.:BCC2107
CAS No.:402957-28-2
- MDL 12330A hydrochloride
Catalog No.:BCC7066
CAS No.:40297-09-4
- Cassyfiline
Catalog No.:BCN4763
CAS No.:4030-51-7
- p-Menth-1-ene-3,6-diol
Catalog No.:BCN5454
CAS No.:4031-55-4
- Isoneobavaisoflavone
Catalog No.:BCN3195
CAS No.:40357-43-5
- Obtusafuran methyl ether
Catalog No.:BCN8103
CAS No.:40357-59-3
- Cannabisin H
Catalog No.:BCN3896
CAS No.:403647-08-5
- Qc 1
Catalog No.:BCC6356
CAS No.:403718-45-6
- 10058-F4
Catalog No.:BCC1050
CAS No.:403811-55-2
Efficient isolation and purification of five products from microbial biotransformation of cinobufagin by high-speed counter-current chromatography.[Pubmed:20574960]
J Sep Sci. 2010 Aug;33(15):2272-7.
An efficient separation method of using high-speed counter-current chromatography was successfully established to directly purify cytotoxic transformed products of cinobufagin by Cordyceps militaris. The two-phase solvent system composed of n-hexane-ethyl acetate-methanol-water (4:6:3:4, v/v) was used in high-speed counter-current chromatography. A total of 9 mg of 4beta,12alpha-dihydroxyl-cinobufagin (1), 15 mg of 12beta-hydroxyl-cinobufagin (2), 8 mg of 5beta-hydroxyl-cinobufagin (3), 12 mg of Deacetylcinobufagin (4) and 6 mg of 3-keto-cinobufagin (5) were obtained in a one-step separation from 400 mg of the crude extract with purity of 98.7, 97.2, 90.6, 99.1 and 99.4%, respectively, as determined by HPLC. Their chemical structures were identified on the basis of (1)H-NMR and (13)C-NMR technology. All products (1-5) showed the potent activities against human carcinoma cervicis (Hela) and malignant melanoma (A375) cells in vitro.
